Showing results (161-170 of 651) with videos related to
Sort By:
Pageof 66
Neuropsychopharmacology Reports|June 13, 2022
Reliability and validity of the Arabic version of the biological rhythms interview of assessment in neuropsychiatryOdeh S Murad, Khaled A Al-DasseanNeuropsychopharmacology Reports|November 29, 2022
Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" projectHitoshi Iida, Tsuyoshi Okada, Kiyotaka Nemoto, et al.Neuropsychopharmacology Reports|June 11, 2022
Establishment to measure oxycodone in plasma with liquid chromatography-tandem mass spectrometrySuguru Ito, Masato Mori, Momoka Matsuo, et al.Neuropsychopharmacology Reports|June 11, 2022
Effects of a web-based relapse prevention program on abstinence: Secondary subgroup analysis of a pilot randomized controlled trialAyumi Takano, Yuki Miyamoto, Tomohiro Shinozaki, et al.Neuropsychopharmacology Reports|June 25, 2022
A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherenceKensuke Miyazaki, Michiko Uchiyama, Chieko Tsushima, et al.Neuropsychopharmacology Reports|May 4, 2022
Perospirone augmentation of escitalopram in the treatment of an adolescent sophophobia (fear of learning) patientKensuke MiyazakiNeuropsychopharmacology Reports|May 4, 2022
Relationship between the early repolarization pattern and a history of suicide attempts among drug-free psychiatric patientsHiroshi Kameyama, Kenichi Sugimoto, Fumitoshi Kodaka, et al.Neuropsychopharmacology Reports|October 14, 2021
Anxiety due to COVID-19 among healthcare providers during pandemic: A web-based cross-sectional survey in IranMahsa Kamali, Mahmood Moosazadeh, Marzieh Azizi, et al.Neuropsychopharmacology Reports|November 3, 2021
Elevated depressive symptoms among newer and younger healthcare workers in Japan during the COVID-19 pandemicNarimasa Katsuta, Kanami Ito, Hiroshi Fukuda, et al.Neuropsychopharmacology Reports|April 18, 2024
Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist surveyYoshiyo Oguchi, Nobumi Miyake, Kumiko AndoPageof 66